Patents by Inventor Meike Dorothee Holm-von Laer

Meike Dorothee Holm-von Laer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220228172
    Abstract: The present invention relates to a novel mechanism to control RNA virus replication and gene expression using a conditional protease approach using a specific protease inhibitor for regulation. More specifically it relates to a single-stranded RNA virus, preferably of the order Mononegavirales, comprising a polynucleotide sequence encoding at least one protein essential for viral transcription and/or replication, a protease and a cleavage site for said protease. The protease can be inhibited using a protease inhibitor and hence the protease and the cleavage site for said protease form a regulatable switch. By changing the insertion site of the regulatable switch from an INTRA- to an INTER-molecular location in the at least one protein essential for viral transcription and/or replication, the effect of the protease inhibitor can be altered from an ON switch to an OFF switch. RNA virus may further encode a heterologous protein, the expression of which is then regulated by regulating viral activity.
    Type: Application
    Filed: June 19, 2020
    Publication date: July 21, 2022
    Applicants: Boehringer Ingelheim International GmbH, ViraTherapeutics GmbH
    Inventors: Meike Dorothee Holm-von Laer, Emmanuel Heilmann, Janine Kimpel, Guido Wollmann, Lisa Egerer, Benedikt Hofer